PI4KB Antikörper (N-Term)

Produktnummer ABIN6242814

Produktdetails anti-PI4KB Antikörper

Target: PI4KB (Phosphatidylinositol 4-Kinase, Catalytic, beta (PI4KB))

Bindungsspezifität: AA 20-51, N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PI4KB Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Homologie: B, M, Rat

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This PI4KCB antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 20-51 amino acids from the N-terminal region of human PI4KCB.

Klon: RB1676

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000. IHC-P: 1:50~100

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-PI4KB Antikörper (ABIN6242814)

Spickler, Lippens, Laberge, Desmeules, Bellavance, Garneau, Guo, Hucke, Leyssen, Neyts, Vaillancourt, Décor, OMeara, Franti, Gauthier: "Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo." in: Antimicrobial agents and chemotherapy, Vol. 57, Issue 7, pp. 3358-68, (2013) (PubMed).

Details zu PI4KB

Target: PI4KB (Phosphatidylinositol 4-Kinase, Catalytic, beta (PI4KB))

Andere Bezeichnung: PI4KCB (PI4KB Produkte)

Synonyme: PIK4CB antikoerper, NV15725 antikoerper, PI4K-beta antikoerper, PI4Kbeta antikoerper, pik4cb antikoerper, NPIK antikoerper, PI4K-BETA antikoerper, PI4K92 antikoerper, PI4KBETA antikoerper, PI4KIIIBETA antikoerper, Pik4cb antikoerper, zgc:152715 antikoerper, AA437822 antikoerper, ESTM41 antikoerper, phosphatidylinositol 4-kinase, catalytic, beta antikoerper, phosphatidylinositol 4-kinase beta antikoerper, phosphatidylinositol 4-kinase, catalytic, beta L homeolog antikoerper, PI4KB antikoerper, LOC100115953 antikoerper, pi4kb antikoerper, Pi4kb antikoerper, pi4kb.L antikoerper

Hintergrund: Phosphoinositides are pivotal precursors to important second messengers and as signaling and molecules. Phosphatidylinositol 4-kinases (PI4Ks) are are crucial regulators of the phosphoinsitide cascade. PI4KCB is a wortmannin-sensitive PI 4-kinase responsible for regulating the synthesis of agonist-sensitive pools of polyphosphoinositides. The cellular reservoir of PI4KCB is predominantly cytosolic, however the protein is is activated strongly by recruitment to the membrane to stimulate phosphatidylinositol 4,5-bisphosphate synthesis at the plasma membrane. PI4KCB contains an N-terminal lipid kinase unique domain, which is shared by members of both the PI3 kinase and PI4 kinase families, and a C-terminal catalytic domain, which defines this protein as a member of a much larger protein/lipid kinase family.

Molekulargewicht: 91379

NCBI Accession: NP_001185702, NP_001185703, NP_001185704, NP_002642

UniProt: Q9UBF8

Pathways: Inositol Metabolic Process